Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo.

Saved in:
Bibliographic Details
Title: Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo.
Authors: Karn, T.1 t.karn@em.uni-frankfurt.de, Denkert, C.2, Weber, K.E.3, Holtrich, U.1, Hanusch, C.4, Sinn, B.V.5, Higgs, B.W.6, Jank, P.2, Sinn, H.P.7, Huober, J.8, Becker, C.4, Blohmer, J.-U.5, Marmé, F.7, Schmitt, W.D.5, Wu, S.6, van Mackelenbergh, M.9, Müller, V.10, Schem, C.11, Stickeler, E.12, Fasching, P.A.13
Source: Annals of Oncology. Sep2020, Vol. 31 Issue 9, p1216-1222. 7p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.05.015